Financials data is unavailable for this security.
View more
Year on year Stryker Corp grew revenues 11.11% from 18.45bn to 20.50bn while net income improved 34.22% from 2.36bn to 3.17bn.
| Gross margin | 63.88% |
|---|---|
| Net profit margin | 16.34% |
| Operating margin | 19.86% |
| Return on assets | 8.77% |
|---|---|
| Return on equity | 18.87% |
| Return on investment | 10.76% |
More ▼
Cash flow in USDView more
In 2023, Stryker Corp increased its cash reserves by 61.12%, or 1.13bn. The company earned 3.71bn from its operations for a Cash Flow Margin of 18.10%. In addition the company used 962.00m on investing activities and also paid 1.59bn in financing cash flows.
| Cash flow per share | 12.02 |
|---|---|
| Price/Cash flow per share | 32.15 |
| Book value per share | 52.86 |
|---|---|
| Tangible book value per share | -3.11 |
More ▼
Balance sheet in USDView more
| Current ratio | 1.91 |
|---|---|
| Quick ratio | 1.22 |
| Total debt/total equity | 0.7685 |
|---|---|
| Total debt/total capital | 0.4345 |
More ▼
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 7.58% and 33.70%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 1.06% |
|---|---|
| Div growth rate (5 year) | 10.16% |
| Payout ratio (TTM) | 33.98% |
| EPS growth(5 years) | 9.49 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 38.36 |
More ▼
